Efeito da talidomida na cicatrização de anastomoses colônicas em ratos by VENEZIANO, Samuel Gama et al.
Acta Cirúrgica Brasileira - Vol 23 (Supplement 1) 2008 - 17
Effect of thalidomide on the healing of colonic anastomosis, in rats
1. Study performed in the Division of Coloproctology of the Department of Surgery and Anatomy of Ribeirão Preto Faculty of Medicine,
University of São Paulo, Brazil.
4-EXPERIMENTAL RESEARCH
ORIGINAL ARTICLE
Alimentary Tract
Effect of thalidomide on the healing of colonic anastomosis, in rats1
Efeito da talidomida na cicatrização de anastomoses colônicas em ratos
Samuel Gama VenezianoI, Leandra Naira Zambelli RamalhoII, Fernando Silva RamalhoIII, Antônio Dorival CamposIV,
José Joaquim Ribeiro da RochaV, Omar FeresVI
I   Fellow Master degree, Division of Coloproctology, Department of  Surgery and Anatomy,  Ribeirão Preto Faculty of Medicine, University
of São Paulo, Brazil.
II  PhD, Professor, Department of  Pathology,  Ribeirão Preto Faculty of Medicine, University of São Paulo, Brazil.
III PhD,  Professor, Department of  Surgery and Anatomy, Ribeirão Preto Faculty of Medicine, University of São Paulo, Brazil.
IV PhD, Professor, Department of  Social Medicine,  Ribeirão Preto Faculty of Medicine, University of São Paulo, Brazil.
V
 PhD, Professor, Division of Coloproctology, Department of  Surgery and Anatomy, Ribeirão Preto Faculty of Medicine, University of São
Paulo, Brazil.
VI
 PhD, Professor, Division of Coloproctology, Department of  Surgery and Anatomy, Ribeirão Preto Faculty of Medicine, University of
São Paulo, Brazil.
ABSTRACT
Purpose: Thalidomide, because of its anti-inflammatory properties, as re-emerged as an option for the treatment of Crohn’s
disease refractory to standard therapy. We studied the effect of thalidomide on the healing of colonic anastomosis.
Methods: Sixty male rats (Rattus norvegicus), were divided into 3 groups of 20 animals each, respectively receiving 0.5 or
1.0 mg/kg thalidomide by the oral route for 7 days, or saline solution (control).  All animals were submitted to continuous
end-to-end anastomosis with 6-0 Prolene sutures. After sacrifice the anastomoses were analyzed macroscopically and
submitted to determination of hydroxyproline, to histology and to immunohistochemistry for metalloproteinase 1,
metalloproteinase 1 inhibitor and vascular endothelial growth factor (VEGF). Results: Statistical analysis of the data
showed no significant difference in macroscopic aspect or hydroxyproline determination (p= 0.5403).  In the
immunohistochemical analysis, the following p values were obtained: p = 0.5817 for VEGF, p = 0.1854 for metalloproteinase
1,  and p = 0.0023 for metalloproteinase 1 inhibitor, with this last value being considered statistically significant. Conclusion:
We conclude that thalidomide influenced collagen maturation. There was a stronger action of metalloproteinases, possibly
indicating a negative tendency for the healing process.
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RESUMO
Objetivo: Sabe-se que agentes farmacológicos podem influenciar no processo de cicatrização. A talidomida, devido às
suas propriedades antiinflamatórias, tem ressurgido como uma opção no tratamento da doença de Cröhn refratária à
terapêutica convencional.  Neste trabalho, estudamos o efeito da talidomida na cicatrização de anastomoses colônicas no
rato.  Métodos: Foram utilizados 60 animais Rattus norvegius, com peso médio de 300g.  Organizou-se 3 grupos de 20
animais, sendo um grupo controle (AC), um grupo (BD), com administração de talidomida 0,5 mg/kg por 7 dias e um grupo
(AD) com administração de talidomida 1,0 mg/kg por 7 dias.  Foi realizada anastomose término-terminal contínua de
prolene 6-0. O sacrifício foi no 7º. dia pós operatório e as anastomoses foram analisadas quanto a aspecto macroscópico,
dosagem de hidroxiprolina, histologia em hematoxilina-eosina e imuno-histoquímica para metaloproteinase 1, inibidor de
metaloproteinase 1 e VEGF. Resultados: Não houve diferença estatisticamente significante para a observação macroscópica
e para dosagem de hidroxiprolina (p=0,5403).  Na análise imunohistoquímica, para VEGF houve p=0,5817, para
metaloproteinase 1, p=0,1854 e para inibidor de metaloproteinase, p=0,0023, considerado estatisticamente significante.
Conclusão: Concluímos que a talidomida influenciou na maturação do colágeno. Notou-se maior ação das metaloproteinases,
que pode significar uma tendência negativa para o processo cicatricial.
Descritores: Talidomida. Anastomose Cirúrgica. Cólon. Cicatrização de Feridas. Deiscência de Ferida Operatória. Doença
de Crohn.
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Introduction
The healing process in general and the healing of
digestive anastomosis in particular has been the subject of
exhaustive studies and has long raised heated debate in
the history of Surgery. The healing of anastomosis is of
fundamental importance for the favorable results that all
surgeons expect for their patients and its failure, with
dehiscence, is one of the main causes of complications in
surgeries of the intestinal tract since dehiscence is
accompanied by high morbidity and mortality due to (para
deixar fecal deveria descrever como cirurgia no colon e não
no trato intestinal como um todo-sugiro deixar somente:
peritonitis) peritonitis and sepsis.1-5
Healing is a complex process depending on multiple
intrinsic and extrinsic factors for successful completion.
The healing of anastomosis is influenced by the general
condition of the patient,6 the blood supply and oxygenation
of tissue,7 the quality of the local vascular network,8 oxygen
tension,9 tension along the anastomosis line,10 blood
volume,11 peritoneal infection,12 sepsis,13 vitamin
deficiency,14 surgical technique,15 surgeon experience,6 as
well as the nature of the surgical intervention and the site
of the anastomosis, whether extra- or intraperitoneal.6 Other
influencing factors are blood transfusions,16 radiotherapy,17
blood viscosity,18 presence of drains close to the
anastomosis,19 patient age,20 clinical nutritional situation,2
dehydration,21 uremia,22 and mechanical intestinal
preparation,23 use of antibiotic prophylaxis in colorectal
surgeries,24 diabetes mellitus,5 obstructive jaundice,25 and
surgical adhesives,26 among other clinical conditions.
The use of pharmacological agents can affect
healing, as previously demonstrated by several authors
using corticosteroids,27 pentoxifylline,28 antineoplastic
drugs,29 and non-hormonal anti-inflammatories.30 Regarding
drugs, thalidomide, although banned several decades back
due to its teratogenic effects, has been pointed out in recent
papers as beneficial for the treatment of Crohn’s disease
resistant to corticotherapy and of difficult clinical
management with conventional drugs.31,32 Thalidomide has
an important immunomodulatory action, inhibiting the action
of tumor necrosis factor (TNF) and having anti-angiogenic
activity, among others.33
In view of the difficult clinical management of
Crohn’s disease refractory to traditional treatment, and
considering the biochemical actions of thalidomide and the
good results obtained with it by some authors in controlled
studies, this drug may gain a place in the therapeutic arsenal
in the near future. Parallel to the possible routine use of the
drug, in some situations surgeries with colonic anastomosis
must be performed in patients with Crohn’s disease in the
presence of long-lasting therapy. This motivated us to test
the influence of thalidomide on the healing of colonic
anastomoses in rats.
Methods
The study was approved by the Ethics Committee
on Animal Experimentation of the Faculty of Medicine of
Ribeirão Preto, University of São Paulo (protocol no. 035/
2005). All procedures were performed in accordance with
the ethical standards laid down in the 1964 Declaration of
Helsinki. Sixty healthy male Wistar rats (Rattus norvegicus)
aged 60 to 80 days and weighing about 300 g were used for
the study. The animals were kept in appropriate animal
facilities under controlled conditions throughout the
experiment, with free access to standard laboratory chow
and water.
The animals were divided at random into three
groups:  Group CA (control animals), consisting of 20 rats
receiving a daily dose of 0.5 ml 0.9% saline solution by
gavage for 7 days. Group LD (a low dose of thalidomide)
consisting of 20 rats  receiving by gavage a daily dose of
0.5 mg/kg thalidomide diluted in 0.5 ml saline solution for 7
days, and Group HD (a high dose of thalidomide) receiving
by gavage a daily dose of 1.0 mg/kg thalidomide diluted in
0.5 ml saline solution for 7 days.
On the eighth day, the animals were operated upon.
After general anesthesia  (apesar de todos nós usarmos o
éter para anesthesia, em revistas internacionais, já recebi
várias críticas por não ter utilizado anesthesia com agente
endovenoso ou intramuscular no lugar do éter), the animals
were submitted to median laparotomy and to colotomy of a
left colon segment of 2.5 to 3.5 cm proximal to the peritoneal
reflexion. Transit was then reconstituted by means of a
continuous end-to-end anastomosis on the total posterior
plane and on the invaginating seromuscular anterior plane
with 6-0 polypropylene sutures and a 1.3 cm cylindrical
needle (Prolene® - Etichon), followed by plane by plane
suture of the cavity.
During the postoperative period, the solutions were
again administered daily by gavage until sacrifice on the
7th postoperative day. The animals were sacrificed  and a
wide median thoracolaparotomy was performed, with full
exposure of the abdomen. The cavity was inspected and
the macroscopic aspect of the colonic anastomosis was
examined, with recording of epiploon adhesions, presence
of peritonitis or abscesses, and presence of macroscopic
dehiscence. After this examination, a segment of distal colon
of about 2 cm containing the anastomosis in its central
portion was resected. The segment was isolated, cleaned
with saline solution, opened longitudinally in the mesenteric
portion, and again cleaned with saline solution.
The fragment was then divided into two portions:
¼ of the anastomosis was placed in ice-cold 0.9% formalin
and immediately sent to the laboratory where it was frozen
at -20°C for later determination of hydroxyproline. The
remaining ¾ of the segment was fixed on cardboard,
immersed in 10% buffered formalin and used for
histopathology and immunohistochemistry.
The following parameters were used to analyze
the healing process of the anastomosis: 1) macroscopic
aspect of the abdominal cavity and of the colonic
anastomosis; 2) biochemical study with the determination
of hydroxyproline along the anastomosis line,34,35 3)
histopathological evaluation (hematoxylin-eosin) with
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analysis of the following indicators.36,37 fibrin-leukocyte
crust, focal necrosis, fibrin deposits, neutrophil exudate,
edema, lymphatic dilatation, vascular congestion, focal
hemorrhage, mucosal regeneration, macrophage infiltration,
granulomas, vascular neoformation, fibroblast proliferation,
and fibrosis. Each indicator was scored as: (0) = absent, (+)
=  mild,  (2+) =  moderate, and (3+) = intense. 4)
Immunohistochemical evaluation for the detection of
markers of metalloproteinase type I (MMP1), MMP1
inhibitor (MMP1I), and vascular endothelial growth factor
(VEGF).  The mean values for fields stained for each marker
were computed.
Statistical analysis
Data regarding the macroscopic analysis of the
anastomoses were analyzed statistically by the Fisher exact
test and by the riddit-score test38 and data regarding
hydroxyproline determination were analyzed by the Kruskal-
Wallis test (nonparametric ANOVA). The qualitative data
obtained by analysis of the sections stained with
hematoxylin-eosin were analyzed using the riddit-scores.
The immunohistochemical data for MMP1, MMP1I and
VEGF were analyzed by the Kruskal-Wallis test. The level
of significance was set at p<0.05 for all analyses.
Results
The data concerning the macroscopic aspect of
the anastomosis are listed in Table 1. There were no
statistically significant differences between groups. The
riddit-score was 0.08 for the absence of adhesions, 0.49 for
fine adhesions and 0.90 for gross adhesions, with no
difference between groups.
The quantitative analysis of hydroxyproline
concentration revealed that the groups did not differ
significantly (p=0.5403). Semi-quantitative analysis of
histological sections stained with hematoxylin-eosin
regarding the parameters listed in table 2 revealed significant
differences between groups for fibrin-leukocyte crust,
hemorrhage, vascular neoformation and fibrosis. The
significance values are given in the table.
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The mean results of immunohistochemical analysis
of stained fields showed non significant differences between
groups for the VEGF marker (p = 0.5817) and for MMP1I (p
= 0.1854). Regarding MMP1, there was a highly significant
difference between groups (p = 0.0023). The multiple
comparison test of Muller showed statistically significant
differences between the control group and the low
thalidomide dose (0.5 mg/kg) group and between the low
thalidomide dose group and the high thalidomide dose
group (1.0 mg/kg), as shown graphically in Figure 1.
Discussion
Healing is a complex process mediated by multiple
factors which culminates in organized collagen synthesis.
The objective of the present study was to investigate how
thalidomide, a drug which could potentially be used in the
future for the control of Crohn’s disease refractory to
classical treatment , interferes with the process of colonic
healing since many patients with this disease require
intestinal surgery during some phase of treatment.
The healing process of intestinal anastomosis
involves complex biochemical and cellular steps, with
collagen synthesis being of fundamental importance. The
basic mechanisms involved in the healing process are:
aggression, inflammation, collagen metabolism,
epithelialization, and wound contraction. After aggression,
which in the present study consisted of a colonic
anastomosis, the first stage involves mechanisms of
vasoconstriction and coagulation, with the formation of a
thrombus and local platelet activation. The activated
platelets release cytokines such as platelet-derived growth
factor  (PDGF), corresponding to the primordial stimulus
for cell chemotaxis, transforming growth factor beta (TGF-
b), platelet activating factor  (PAF), fibronectin, and
serotonin. PAF stimulates the arrival of fibroblasts as well
as polymorphonuclear cells, mast cells and macrophages,
which complement the inflammatory reaction. This
equilibrated inflammation is fundamental for the occurrence
of healing. The mediators dilate local capillaries, increasing
vascular permeability, white cell diapedesis and macrophage
and neutrophil taxis into the wound. The macrophages then
promote phagocytosis of foreign matter, bacteria and clots,
in addition to releasing their own cytokines. They also play
a fundamental role in fibroblast activation and stimulation
for collagen synthesis.39-41
On the second day after the execution of the
anastomosis, the entire inflammatory process will promote
accelerated collagen production at the site of the wound.
During collagen deposition (with greater expression from
the 4th to the 12th day) the formed collagen is concomitantly
degraded by the action of metalloproteinases, with
collagenase being the most important enzyme in this group.
This enzymatic degradation occurs in an ordered manner to
guarantee synthesis, adequate fiber intercrossing, removal
of excess material, and modulation of healing. This collagen
synthesis-lysis balance is finally regulated and guarantees
correct healing.2 In addition to these lytic enzymes, an
inhibitory group also participates, the so-called
metalloproteinase inhibitors, which are fundamental to
guarantee the correct modulation of the enzymatic system.
These enzymes are significantly expressed only at sites
that need healing, especially along the suture lines, and do
not appear in other parts of the tissue outside the necessary
site.42
Using histochemical techniques, the presence of
metalloproteinases is detected as early as during the first
24 hours of anastomosis healing, especially in the
extracellular matrix of the mucosa. After 72 hours, they are
still present in the mucosa but they are also detected in
deeper layers, especially in fibrous tissues, where their
remodeling lytic effect is needed. Their action continues
while there is healing activity and is modulated by inhibitory
enzymes.43 It has been already demonstrated that elevated
submucosal collagen degradation by metalloproteinases can
predispose to the dehiscence of anastomosis44 and that the
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inhibition of metalloproteinases can have a promising action
in healing.45,46 Thus, a firmer scar is expected to occur in a
tissue where the action of metalloproteinase inhibitors
prevails, and a looser and more tenuous scar is expected to
occur in situations of imbalance towards the presence of
metalloproteinases (greater collagen degradation).
The concept of immunohistochemical analysis of
VEGF also applies to the healing conditions, since greater
and better collagen synthesis is expected in a tissue with
an ample blood supply and with good vascular neoformation.
Angiogenesis is a complex cellular phenomenon that leads
to the formation of new capillaries by pre-existing
endothelial cells.47 Cells such as macrophages, monocytes,
lymphocytes, fibroblasts and endothelial cells can interfere
with angiogenesis by releasing substances that promote or
inhibit the process.  In addition to VEGF, a potent mitogen
exclusively acting on endothelial cells,48 other molecules
are implicated in angiogenesis, such as fibroblast-derived
growth factor (FGF), TGF-β and PDGF. Thalidomide can
inhibit the angiogenesis stimulated by the binding of VEGF
to integrin α−v-β 5,49 but the mechanism of this effect is
unknown.50
Macroscopic analyses of the anastomosis
Macroscopic analysis of the animals’ abdominal
cavity at the time of sacrifice revealed a tendency to lower
formation of adhesions or of more tenuous adhesions.
Intracavity adhesions are the product of inflammation and
of the response occurring after surgical trauma, in which
TNF, IL-1, IL-4, IL-6 and IL-10 are involved.51 A lower
incidence of adhesions has been experimentally
demonstrated in rabbits submitted to colonic anastomosis
and intracavity thalidomide injection.52 The authors
attributed their results to the known anti-TNF effects of
thalidomide, which indirectly inhibits the formation of
adhesions. There was no significant difference between
groups regarding adhesions. However, when we analyzed
the study population (n = 60 animals) in terms of the
probability of adhesions, comparison of the mean riddit for
the various groups (control x low thalidomide dose, control
x high thalidomide dose, and low x high thalidomide dose)
showed that, even though the P value was nonsignificant,
the animals in the high thalidomide dose group had a higher
probability of presenting a lower incidence of adhesions.
Analysis of hydroxyproline concentration
Overall analysis of collagen synthesis by the
determination of hydroxyproline showed no statistically
significant difference between groups. The drug did not
affect gross collagen production but may have acted on
the way this collagen is organized during its maturation.
Histopathological analysis
Histological analysis using hematoxylin-eosin
revealed a significant difference in fibrosis, necrosis, fibrin-
leukocyte crust, edema, hemorrhage, and vascular
neoformation vascular between the thalidomide-treated
animals and the controls. There was less edema in the group
treated with thalidomide.  The literature has reported reduced
vascular permeability after treatment with thalidomide, with
a consequent reduction of edema, possibly due to an
immunomodulatory effect of the drug,53 since lower vascular
permeability implies lower chemotaxis of inflammatory cells
in addition to lower edema.
In the treated animals there was a lower tendency
to the formation of fibrosis at the site of anastomosis. Again,
the immunomodulating effects of thalidomide leading to
reduction of the inflammatory response may have
influenced this lower formation of fibrosis,51 with the same
mechanism being responsible for lower necrosis and a
smaller fibrin-leukocyte crust in the treated animals.
In the control group there was a lower incidence
of micro-hemorrhage. Thalidomide has been previously
implicated in situations of teratogenesis explained by
hemorrhagic processes.54,55
We observed a higher tendency to the occurrence
of vascular neoformation in the anastomoses of the animals
treated with the drug.  Thalidomide has been reported to
have a well-documented anti-angiogenic effect.49,56 This
finding may be due to the fact that vascular neoformation is
a complex and little understood process, with other
stimulating factors possibly having exceeded in vivo the
inhibitory effects of the drug tested.
Immunohistochemical coordination
The results showed no significant difference
between the 3 groups regarding the expression of VEGF at
the level of the anastomosis, and histological analysis did
not show a statistically significant difference between the
high dose group and the control.  There was better vascular
neoformation in the low dose group (a small difference),
suggesting that, if a possible anti-angiogenic effect
occurred, it did not manifest as an action on this parameter
and did not impair anastomosis healing regarding the
parameters analyzed.
There was a high accumulation of
metalloproteinases in the group treated with a high
thalidomide dose compared to control and to the group
treated with a low dose, but without corresponding higher
rates of dehiscence.  The drug probably induced fibroblasts
and inflammation-mediating cells to synthesize more
metalloproteinases, with some response regarding control
with the inhibitors, although the concentrations of
metalloproteinase inhibitors did not differ significantly
between groups.
Conclusion
The present results show that thalidomide
somehow affected collagen maturation, with the formation
of anastomosis with less necrosis, less fibrosis, more
remodeling, and a less pronounced fibrin-leukocyte crust.
The drug had no significant effect on the action of VEGF
and did not cause major damage to the vascularization of
the anastomosis. We also noted a greater action of
metalloproteinase, which may indicate a negative tendency
regarding the healing process.
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Comments:
Most patients with Crohn’s disease ultimately require one or more operations over their lifetime (78% and 90% after 20 and
30 years). Even with the availability of various immunosuppressive therapies such as azathioprine, mercaptopurine, and
methotrexate, the treatment of patients with Crohn’s disease (CD) refractory to steroids still remains a clinical challenge.
TNF- α is considered to be centrally involved in the inflammatory process in CD. Thalidomide, developed in the 1950s as
a sedative but subsequently withdrawn from widespread use in the 1960s because of teratogenicity, is an agent with TNF-
α  suppressive property. Was introduced into the therapy of CD by Wettstein and Meagher. In this context, there is a real
concern that thalidomide can affect the healing of colonic anastomosis in such patients, what makes this study a very
important one. As showed by the authors in a rat model, although thalidomide didn’t affect the concentration of
hydroxyproline on colonic anastomosis, the collagen maturation was altered, causing some histopathological changes
between groups. Was also observed that the drug promoted greater action of metalloproteinase, what could lead to a
higher rate of dehiscence, a fact that didn’t happen at all. More studies must be stimulated on this subject.
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